Parthvimeda Gau Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 12-07-2024
- Paid Up Capital ₹ 6.00 M
as on 12-07-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 6.67 Cr
as on 12-07-2024
- Satisfied Charges ₹ 3.73 Cr
as on 12-07-2024
- Revenue 21.01%
(FY 2020)
- Profit -63.38%
(FY 2020)
- Ebitda 8.30%
(FY 2020)
- Net Worth 1.83%
(FY 2020)
- Total Assets 6.74%
(FY 2020)
About Parthvimeda Gau Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹6.67 Cr. The company has closed loans amounting to ₹3.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Agarwal and Madan Agarwal serve as directors at the Company.
- CIN/LLPIN
U24100GJ2013PTC073419
- Company No.
073419
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Parthvimeda Gau Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Agarwal  | Additional Director | 01-Jun-2021 | Current |
| Madan Agarwal | Director | 02-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Parthvimeda Gau Pharma.
Parthvimeda Gau Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 21.01% increase. The company also saw a substantial fall in profitability, with a 63.38% decrease in profit. The company's net worth moved up by a moderate rise of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parthvimeda Gau Pharma?
In 2019, Parthvimeda Gau Pharma had a promoter holding of 90.03% and a public holding of 9.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parthvimeda Panchgavy Utpad Private LimitedActive 15 years 17 daysManish Agarwal and Madan Agarwal are mutual person
Parthvimeda Agro Food & Beverages Private LimitedActive 11 years 6 monthsManish Agarwal and Madan Agarwal are mutual person
- Redefined Cardboard Private LimitedActive 11 years 4 months
Manish Agarwal and Madan Agarwal are mutual person
- Dev Woodzone Private LimitedActive 10 years 6 months
Manish Agarwal and Madan Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2020 | ₹1.92 Cr | Open |
Others Creation Date: 10 Jul 2019 | ₹4.00 Cr | Open |
Others Creation Date: 06 Jul 2018 | ₹6.00 M | Open |
How Many Employees Work at Parthvimeda Gau Pharma?
Unlock and access historical data on people associated with Parthvimeda Gau Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parthvimeda Gau Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parthvimeda Gau Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
